Armada Acquisition III and Brains Bioceutical Announce Business Combination
The proposed combination includes a Nasdaq listing intended to advance Brains’ pharmaceutical API manufacturing and drug development.
Story updates
11:33:17 AM UTC
SquawkNews
ARMADA ACQUISITION CORP III - COMBINED COMPANY TO OPERATE AS BRAINS THERAPEUTICS CORP. AND TRADE ON